# Doxazosin mesylate

NDC: 59762-1391
Generic name: doxazosin mesylate
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: NDA AUTHORIZED GENERIC
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260803

FDA application: NDA019668

## Active ingredients

- DOXAZOSIN MESYLATE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59762-1391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59762-1391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e524986-7903-416f-b2b8-d27295103e75